BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 29363217)

  • 1. Predicting drug efficacy in chronic low back pain by quantitative sensory tests.
    Schliessbach J; Siegenthaler A; Bütikofer L; Vuilleumier P; Jüni P; Stamer U; Arendt-Nielsen L; Curatolo M
    Eur J Pain; 2018 May; 22(5):973-988. PubMed ID: 29363217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Linking altered central pain processing and genetic polymorphism to drug efficacy in chronic low back pain.
    Siegenthaler A; Schliessbach J; Vuilleumier PH; Juni P; Zeilhofer HU; Arendt-Nielsen L; Curatolo M
    BMC Pharmacol Toxicol; 2015 Sep; 16():23. PubMed ID: 26376691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative sensory tests fairly reflect immediate effects of oxycodone in chronic low-back pain.
    Schliessbach J; Siegenthaler A; Bütikofer L; Vuilleumier P; Jüni P; Arendt-Nielsen L; Curatolo M
    Scand J Pain; 2017 Oct; 17():107-115. PubMed ID: 28850362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of single-dose imipramine on chronic low-back and experimental pain. A randomized controlled trial.
    Schliessbach J; Siegenthaler A; Bütikofer L; Limacher A; Juni P; Vuilleumier PH; Stamer U; Arendt-Nielsen L; Curatolo M
    PLoS One; 2018; 13(5):e0195776. PubMed ID: 29742109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analgesic effect of clobazam in chronic low-back pain but not in experimentally induced pain.
    Schliessbach J; Vuilleumier PH; Siegenthaler A; Bütikofer L; Limacher A; Juni P; Zeilhofer HU; Arendt-Nielsen L; Curatolo M
    Eur J Pain; 2017 Sep; 21(8):1336-1345. PubMed ID: 28418172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting the analgesic effect to oxycodone by 'static' and 'dynamic' quantitative sensory testing in healthy subjects.
    Eisenberg E; Midbari A; Haddad M; Pud D
    Pain; 2010 Oct; 151(1):104-109. PubMed ID: 20621419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolerability, Safety, and Effectiveness of Oxycodone DETERx in Elderly Patients ≥65 Years of Age with Chronic Low Back Pain: A Randomized Controlled Trial.
    Kopecky EA; Vaughn B; Lagasse S; O'Connor M
    Drugs Aging; 2017 Aug; 34(8):603-613. PubMed ID: 28600725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety of oxymorphone extended release in chronic low back pain: results of a randomized, double-blind, placebo- and active-controlled phase III study.
    Hale ME; Dvergsten C; Gimbel J
    J Pain; 2005 Jan; 6(1):21-8. PubMed ID: 15629415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analgesic efficacy and safety of oxycodone in combination with naloxone as prolonged release tablets in patients with moderate to severe chronic pain.
    Vondrackova D; Leyendecker P; Meissner W; Hopp M; Szombati I; Hermanns K; Ruckes C; Weber S; Grothe B; Fleischer W; Reimer K
    J Pain; 2008 Dec; 9(12):1144-54. PubMed ID: 18708300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does long-term opioid therapy reduce pain sensitivity of patients with chronic low back pain? Evidence from quantitative sensory testing.
    Wang H; Fischer C; Chen G; Weinsheimer N; Gantz S; Schiltenwolf M
    Pain Physician; 2012 Jul; 15(3 Suppl):ES135-43. PubMed ID: 22786452
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient-reported health-related quality of life, work productivity, and activity impairment during treatment with ALO-02 (extended-release oxycodone and sequestered naltrexone) for moderate-to-severe chronic low back pain.
    Weil AJ; Masters ET; Barsdorf AI; Bass A; Pixton G; Wilson JG; Wolfram G
    Health Qual Life Outcomes; 2017 Oct; 15(1):202. PubMed ID: 29041942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tapentadol immediate release versus oxycodone immediate release for treatment of acute low back pain.
    Biondi D; Xiang J; Benson C; Etropolski M; Moskovitz B; Rauschkolb C
    Pain Physician; 2013; 16(3):E237-46. PubMed ID: 23703422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effect of opioids in patients with chronic pancreatitis: an experimental pain study.
    Staahl C; Dimcevski G; Andersen SD; Thorsgaard N; Christrup LL; Arendt-Nielsen L; Drewes AM
    Scand J Gastroenterol; 2007 Mar; 42(3):383-90. PubMed ID: 17354119
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reliability of static and dynamic quantitative sensory testing in patients with painful chronic pancreatitis.
    Olesen SS; van Goor H; Bouwense SA; Wilder-Smith OH; Drewes AM
    Reg Anesth Pain Med; 2012; 37(5):530-6. PubMed ID: 22854397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The analgesic effect of codeine as compared to imipramine in different human experimental pain models.
    Enggaard TP; Poulsen L; Arendt-Nielsen L; Hansen SH; Bjørnsdottir I; Gram LF; Sindrup SH
    Pain; 2001 May; 92(1-2):277-82. PubMed ID: 11323149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can quantitative sensory testing predict responses to analgesic treatment?
    Grosen K; Fischer IW; Olesen AE; Drewes AM
    Eur J Pain; 2013 Oct; 17(9):1267-80. PubMed ID: 23658120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative sensory tests (QST) are promising tests for clinical relevance of anti-nociceptive effects of new analgesic treatments.
    Jääskeläinen SK
    Scand J Pain; 2017 Oct; 17():144-145. PubMed ID: 28865379
    [No Abstract]   [Full Text] [Related]  

  • 18. Oxytrex minimizes physical dependence while providing effective analgesia: a randomized controlled trial in low back pain.
    Webster LR; Butera PG; Moran LV; Wu N; Burns LH; Friedmann N
    J Pain; 2006 Dec; 7(12):937-46. PubMed ID: 17157780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effectiveness of Tapentadol Prolonged Release (PR) Compared with Oxycodone/Naloxone PR for the Management of Severe Chronic Low Back Pain with a Neuropathic Component: A Randomized, Controlled, Open-Label, Phase 3b/4 Study.
    Baron R; Likar R; Martin-Mola E; Blanco FJ; Kennes L; Müller M; Falke D; Steigerwald I
    Pain Pract; 2016 Jun; 16(5):580-99. PubMed ID: 26095455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of rofecoxib and a multidose oxycodone/ acetaminophen regimen for the treatment of acute pain following oral surgery: a randomized controlled trial.
    Chang DJ; Desjardins PJ; Bird SR; Black P; Chen E; Petruschke RA; Geba GP
    Curr Med Res Opin; 2004 Jun; 20(6):939-49. PubMed ID: 15200753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.